Home
Scholarly Works
Reduction in targeted potentially inappropriate...
Conference

Reduction in targeted potentially inappropriate medication use in elderly inpatients: a pragmatic randomized controlled trial

Abstract

PurposeThe use of potentially inappropriate medications (PIMs) in hospitalized older adults is a complex problem, but the use of computerized alert systems (CAS) has shown some potential. The study’s objective is to assess the change in PIM use with a CAS-based pharmacist-physician intervention model compared to usual clinical care.MethodsPragmatic single-site randomized controlled trial was conducted at a university teaching hospital. Hospitalizations identified with selected Beers or STOPP criteria were randomized to usual clinical care or to the CAS-based pharmacist-physician intervention. The primary outcome was PIM drug cessation or dosage decrease. Clinical relevance of the CAS alerts was assessed.ResultsAnalyses included 231 patients who had 128 and 126 hospitalizations in the control and intervention groups, respectively. Patients had a mean age of 81, and 60% were female. In the intervention compared to the control group, drug cessation or dosage decrease were more frequent at 48 h post-alert (45.8 vs 15.9%; absolute difference 30.0%; 95%CI 13.8 to 46.1%) and at discharge from the hospital (48.1 vs 27.3%; absolute difference 20.8%; 95%CI 4.6 to 37.0%). In a post hoc analysis of all alerts, regardless of their clinical relevance, the absolute difference in drug cessation or dosage decrease between the intervention and control groups was 16.2% (95%CI 2.9 to 29.6%) at 48 h and 8.0% (95%CI −4.0 to 20.0%) at discharge from the hospital.ConclusionsIn hospitalized older adults, a CAS-based pharmacist-physician intervention, compared to usual clinical care, resulted in significant higher number of drug cessation and dosage reductions for targeted PIMs.

Authors

Cossette B; Éthier J-F; Joly-Mischlich T; Bergeron J; Ricard G; Brazeau S; Caron M; Germain O; Payette H; Kaczorowski J

Volume

73

Pagination

pp. 1237-1245

Publisher

Springer Nature

Publication Date

October 1, 2017

DOI

10.1007/s00228-017-2293-4

Conference proceedings

European Journal of Clinical Pharmacology

Issue

10

ISSN

0031-6970

Contact the Experts team